Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Basiliximab reduces renal allograft rejection in phase III trial

Nov. 19, 1997

Second report of clinical efficacy for rotavirus vaccine

Nov. 18, 1997

Novartis submits BLA for Simulect in U.S.

Nov. 17, 1997

Immunological method for preventing ALL in children available for licensing

Nov. 17, 1997

Peptide + ciclosporin combination improves renal allograft survival and function

Nov. 14, 1997

Anti-CD45 MAb prolongs islet xenograft survival in diabetic mice

Nov. 14, 1997

BioChem Pharma moves cell culture-based influenza vaccine to phase II/III

Nov. 12, 1997

LXR to commence pivotal trials with HK-Cardiosol

Nov. 10, 1997

Mechanism of action of triptolide investigated in human T-cells

Nov. 10, 1997

Confirmatory trials of Alpha-Beta's Betafectin to begin

Nov. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...